| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
42,520,000 |
| Market
Cap: |
9.57(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.17 - $0.2563 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Venus Concept is a global medical technology company that develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies. Co.'s products include: Venus Legacy, in which the Venus Legacy BX is a noninvasive device intended for use in dermatological and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick Skin Types I-IV; Venus Versa, in which the Venus Versa system is a multi-application device intended for use in aesthetic and cosmetic procedures; and Venus Glow, in which Venus Glow is a motorized dermabrasion device.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,072,782 |
| Total Buy Value |
$0 |
$0 |
$0 |
$515,680 |
| Total People Bought |
0 |
0 |
0 |
7 |
| Total Buy Transactions |
0 |
0 |
0 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
102,859 |
| Total Sell Value |
$0 |
$0 |
$0 |
$26,183 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hollmig Stanley Tyler |
Director |
– • – |
2022-05-24 |
4 |
B |
$0.64 |
$25,720 |
D/D |
40,000 |
40,000 |
2.39 |
-39% |
|
| Serafino Domenic |
Chief Executive Officer |
• • – |
2022-05-20 |
4 |
B |
$0.75 |
$48,750 |
D/D |
65,000 |
933,758 |
2.81 |
-39% |
|
| Portaro Ross |
President Global Sales |
• – – |
2022-05-17 |
4 |
B |
$0.85 |
$8,500 |
D/D |
10,000 |
60,000 |
2.74 |
-44% |
|
| Portaro Ross |
President Global Sales |
• – – |
2021-12-16 |
4 |
B |
$1.35 |
$27,000 |
D/D |
20,000 |
50,000 |
2.74 |
-25% |
|
| Sullivan Keith J |
Director |
– • – |
2021-12-15 |
4 |
B |
$1.25 |
$100,000 |
I/I |
80,000 |
80,000 |
2.1 |
-23% |
|
| Barry Scott |
|
• • • |
2021-12-15 |
4 |
B |
$1.25 |
$4,900,000 |
I/I |
3,920,000 |
16,337,856 |
0.01 |
-23% |
|
| Essex Woodlands Ix, Llc |
|
• • • |
2021-12-15 |
4 |
B |
$1.25 |
$189,515 |
I/I |
151,612 |
16,337,856 |
0.01 |
-23% |
|
| Essex Woodlands Ix, Llc |
|
• • • |
2021-12-15 |
4 |
B |
$1.25 |
$4,710,485 |
D/D |
3,768,388 |
15,705,966 |
0.01 |
-23% |
|
| Healthquest Venture Management Ii, L.l.c. |
10% Owner |
– – • |
2021-12-15 |
4 |
B |
$1.25 |
$2,000,000 |
D/D |
1,600,000 |
6,795,621 |
2.45 |
-23% |
|
| Kong Garheng |
Director |
– • • |
2021-12-15 |
4 |
B |
$1.25 |
$2,000,000 |
I/I |
1,600,000 |
6,795,621 |
2.25 |
-23% |
|
| Portaro Ross |
President Global Sales |
• – – |
2021-12-03 |
4 |
B |
$1.35 |
$40,500 |
D/D |
30,000 |
30,000 |
2.74 |
7% |
|
| Serafino Domenic |
Chief Executive Officer |
• • – |
2021-11-19 |
4 |
B |
$1.48 |
$25,111 |
D/D |
17,000 |
831,258 |
2.81 |
9% |
|
| Serafino Domenic |
Chief Executive Officer |
• • – |
2021-11-17 |
4 |
B |
$1.60 |
$24,812 |
D/D |
15,500 |
814,258 |
2.81 |
-12% |
|
| Iger Yoni |
VP, RA/QA/Clinical Affairs |
• – – |
2021-08-18 |
4 |
B |
$1.94 |
$10,051 |
D/D |
5,181 |
5,181 |
2.74 |
-10% |
|
| Saudi Economic & Development Securities Co |
10% Owner |
– – • |
2021-07-12 |
4 |
S |
$3.25 |
$162,563 |
I/I |
(50,000) |
922,456 |
|
48% |
|
| Saudi Economic & Development Securities Co |
10% Owner |
– – • |
2021-07-09 |
4 |
S |
$3.24 |
$188,315 |
I/I |
(57,933) |
972,456 |
|
47% |
|
| Saudi Economic & Development Securities Co |
10% Owner |
– – • |
2021-07-08 |
4 |
S |
$3.20 |
$320,270 |
I/I |
(100,000) |
1,030,389 |
|
47% |
|
| Saudi Economic & Development Securities Co |
10% Owner |
– – • |
2021-07-02 |
4 |
S |
$3.20 |
$46,973 |
I/I |
(14,679) |
1,130,389 |
|
39% |
|
| Saudi Economic & Development Securities Co |
10% Owner |
– – • |
2021-07-01 |
4 |
S |
$3.20 |
$101,181 |
I/I |
(31,619) |
1,145,068 |
|
39% |
|
| Saudi Economic & Development Securities Co |
10% Owner |
– – • |
2021-06-28 |
4 |
S |
$3.20 |
$53,267 |
I/I |
(16,646) |
1,176,687 |
|
37% |
|
| Serafino Domenic |
Chief Executive Officer |
• • – |
2021-06-14 |
4 |
B |
$2.46 |
$98,244 |
D/D |
40,000 |
798,758 |
2.81 |
-15% |
|
| Zaring Chad A |
CCO |
• – – |
2021-06-01 |
4 |
B |
$2.09 |
$83,600 |
D/D |
40,000 |
80,000 |
2.74 |
9% |
|
| Madryn Health Advisors, Lp |
10% Owner |
– – • |
2020-12-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,680,598 |
|
-12% |
|
| Serafino Domenic |
Chief Executive Officer |
• • – |
2020-11-20 |
4 |
OE |
$1.35 |
$21,041 |
I/I |
15,586 |
15,586 |
|
- |
|
| Serafino Domenic |
Chief Executive Officer |
• • – |
2020-11-20 |
4 |
OE |
$0.45 |
$139,951 |
D/D |
311,003 |
758,758 |
|
- |
|
32 Records found
|
|
Page 1 of 2 |
|
|
